ID119031166
/ Ildong
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 11, 2024
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
(clinicaltrials.gov)
- P1 | N=67 | Terminated | Sponsor: IlDong Pharmaceutical Co Ltd | Recruiting ➔ Terminated; Sponsor have decided to cancel the trial
Trial termination
January 06, 2024
Intestine FXR agonist ID119031166 modulates ethanol and bile acid metabolism in ethanol-fed hamsters
(APASL 2024)
- "Our findings suggest that ID119031166 modulates ethanol and bile acid metabolism by regulating key metabolic genes in chronic ethanol exposure."
Hepatology • Inflammation • ALDH1A1 • CYP2E1 • IL6 • TGFB1
November 03, 2022
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
(clinicaltrials.gov)
- P1 | N=78 | Recruiting | Sponsor: IlDong Pharmaceutical Co Ltd
New P1 trial
1 to 3
Of
3
Go to page
1